Cti Biopharma Corp buy Needham & Company LLC
Start price
06.03.23
/
50%
€4.56
Target price
06.03.24
€8.42
Performance (%)
83.36%
End price
07.03.24
-
Summary
This prediction is currently being closed. With a performance of 83.36% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cti Biopharma Corp | - | - | - | - |
| iShares Core DAX® | 1,16 % | 3,68 % | 4,55 % | 49,40 % |
| iShares Nasdaq 100 | 2,59 % | 3,10 % | 36,50 % | 89,17 % |
| iShares Nikkei 225® | 7,11 % | 10,60 % | 61,22 % | 69,64 % |
| iShares S&P 500 | 1,26 % | 1,67 % | 25,23 % | 65,89 % |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten